Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 16Thoracic 4Head & Neck 4Other solid neoplasm 3Gastrointestinal 3Breast 3Tumor-Agnostic 2Other neoplasm 2Dermatologic 2Sarcoma 1Other hematologic neoplasm 1Other 1Lymphoid 1CNS 1

Conditions

Melanoma 1Carcinoma, Basal Cell 1

Interventions

pembrolizumab 339Nivolumab 305Ipilimumab 274Cyclophosphamide 194aldesleukin 148Interleukin-2 110fludarabine phosphate 106trametinib 85Temozolomide 83Dacarbazine 81fludarabine 80dabrafenib 77Radiotherapy 75Biopsy 75Vemurafenib 71Imiquimod 53Bevacizumab 51sargramostim 50Radiosurgery 49Peripheral Blood Stem Cell Transplantation 49Paclitaxel 49Magnetic Resonance Spectroscopy 49Aminolevulinic Acid 49binimetinib 48Carboplatin 48Specimen Handling 47Blood Specimen Collection 47cemiplimab 46Cisplatin 453-ingenyl angelate 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Calcitriol × Dermatologic × Clear all
NCT00301067 2019-06-04

Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma

Northwestern University

Phase 1/2 Completed
20 enrolled 9 charts
Dermatologic

Melanoma

NCT01358045 2015-01-13

Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma

Maastricht University Medical Center

Phase 2 Completed
128 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡